RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Conditions
- COPD Exacerbation Acute
- COPD With Acute Lower Respiratory Infection
- Rhinovirus
- Virus Diseases
- Virus Infection, RNA
- Enterovirus
- Enterovirus Infections
- Rhinovirus Infection
- Infection Viral
- Respiratory Complication
- Respiratory Disease
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Respiratory Viral Infection
- Upper Resp Tract Infection
- Upper Respiratory Tract Infections
- Upper Respiratory Disease
- Upper Respiratory Disorder
- Upper Respiratory Disease, Acute
- Upper Respiratory Infection Viral
- Infections, Respiratory
- Infections
- Copd
- Viral Infection
- Emphysema or COPD
- Lower Respiratory Disease
- Lower Respiratory Disorder
- Lower Respiratory Tract and Lung Infections
- Pulmonary Disease
- Pulmonary Disease, Chronic Obstructive
- Respiratory Disease Chronic
- Lung Diseases
- Lung Disease Chronic
- Obstructive Pulmonary Disease
- Chronic Lower Respiratory Diseases
- Chronic Respiratory Disease
Interventions
- DRUG: Vapendavir
- DRUG: Placebo
Sponsor
Altesa Biosciences, Inc.
Collaborators